Alifax Holding Spa v. Alcor Scientific Inc.

District Court, D. Rhode Island·Decided September 1, 2021·No. 1:14-cv-00440·Unknown

Opinion

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF RHODE ISLAND ___________________________________ ) ALIFAX HOLDING SPA, ) ) Plaintiff, ) ) v. ) C.A. No. WES 14-440 ) ALCOR SCIENTIFIC INC.; and ) FRANCESCO A. FRAPPA, ) ) Defendants. ) ___________________________________)

MEMORANDUM AND ORDER After Defendants filed a Request for Case Management Order, ECF No. 354, the Court ruled, inter alia, that the parties would not be allowed to introduce any new evidence at retrial and that the Court’s evidentiary rulings made prior to the first trial would apply to the second. See July 16, 2021 Mem. & Order 5, 8, ECF No. 357.1 However, the Court did not reach a decision on Defendants’ argument that Alifax should be limited to nominal damages, as Alifax had not substantively responded to that contention. See id. at 8-9. Having solicited further briefing on the issue, the Court now concludes that Alifax will be precluded from seeking compensatory damages at the second trial. Alifax’s theory of damages is as follows. At some point prior to the June 2012 trade show for the American Association for

1 This Order assumes familiarity with those that precede it. Clinical Chemistry, Alcor and Francesco Frappa misappropriated Alifax’s conversion algorithm and used it in an iSED prototype. Alifax Holding Spa v. Alcor Sci. Inc., 404 F. Supp. 3d 552, 576-

77 (D.R.I. 2019). Thanks in part to the illicitly borrowed algorithm, Alcor’s trade show presentation, which was buoyed by its bullish claims regarding the iSED’s capabilities, was a hit. Id. at 572, 576-77. Without Alifax’s algorithm, Alcor would have been forced to spending months developing its own, and it could not have made such a successful showing. Id. at 576. Because the June 2012 exposition generated sales of the iSED and related products, Alcor’s misdeeds led to its unjust enrichment. Id. For this theory to hold up, Alifax needs evidence (1) that the alleged misappropriation gave Alcor a head start and (2) that the head start helped to bring about certain earnings over the following months or years. While Alifax has (marginal) evidence

of a head start, there is no admissible evidence tying that head start to a measure of unjust enrichment. 1. Evidence of a Head Start At the first trial, Dr. Bergeron testified that it would have taken Alcor months to produce an original conversion algorithm. Trial Tr. vol. 3, 115:23-116:1, ECF No. 333. Although this opinion was not contained in his expert report, Defendants did not object. See Alifax Holding Spa, 404 F. Supp. 3d at 576 n.30 (citing Trial Tr. vol. 3, 115:23-116:9, 119:10-120:6); April 30, 2019 Mem. & Order 10 & n.8, 12-13 & n.11, ECF No. 288; Expert Report of Dr. Brian Bergeron ¶¶ 44-46, ECF No. 144-11. However, on retrial, Defendants presumably would object on the basis that the opinion

was not disclosed, and their objection would be sustained. See Fed. R. Civ. P. 26(a)(2)(D), 37(c)(1). Dr. Bergeron’s surprise statement was not the only evidence to support the head start theory. According to some evidence, when Alcor ultimately set out to develop its own algorithm, the effort spanned from January to June 2013. See Alifax Holding Spa, 404 F. Supp. 3d at 570, and documents cited; id. at 576. For the sake of this Order, the Court will assume that this evidence would be sufficient for a jury to infer that Alcor could not have developed an original algorithm in time for the trade show. 2. Evidence Linking the Head Start to Unjust Enrichment To show unjust enrichment, a plaintiff “has the burden of

producing evidence permitting at least a reasonable approximation of the amount of the wrongful gain.” Restatement (Third) of Restitution and Unjust Enrichment § 51(5)(d). And of course, a plaintiff must provide timely disclosures regarding the witnesses and evidence through which the plaintiff will attempt to establish damages. See Fed. R. Civ. P. 26(a)(2)(D), 26(e), 37(c)(1). Prior to the first trial, the only damages witness disclosed by Alifax was Christopher Bokhart. See Alifax Holding Spa, 404 F. Supp. 3d at 580; see also Pls.’ Initial Disclosures 5, ECF No. 284-1; Plaintiff’s First Am. Answers to Defs.’ First Set of Interrogatories 29, ECF No. 284-2. Although the Court ruled that Bokhart’s expert opinions regarding damages stemming from

conversion algorithm misappropriation were “unreliable and inadmissible[,]” April 30, 2019 Mem. & Order 13, the Court permitted Bokhart to testify as a summary witness pursuant to Rule 1006 of the Federal Rules of Evidence, Alifax Holding Spa, 404 F. Supp. 3d at 580 (citing Trial Tr. vol. 11, at 20:11-22, 33:10-25). As the Court noted in its prior Order granting in part the motions for new trial, that decision was made in error. Id. at 581-82. Nonetheless, Alifax contends that it should once again be permitted to introduce Bokhart’s testimony, this time through an “appropriately limited summary examination.” Alifax’s Mem. Regarding Damages 4, ECF No. 358. “[T]o prove the content of voluminous writings, recordings,

or photographs that cannot be conveniently examined in court[,]” a party may use summary evidence, either documentary or testimonial. Fed. R. Evid. 1006. Bokhart’s summary testimony was impermissible, among other reasons,2 because it was “too closely entwined with his excluded expert opinion to be cleanly dissected

2 For example, Bokhart did not summarize already admitted evidence. Alifax Holding Spa, 404 F. Supp. 3d at 581 (“[T]he key to admissibility is that the summary witness’s testimony does no more than analyze facts already introduced into evidence . . . .” (quoting United States v. Stierhoff, 549 F.3d 19, 28 (1st Cir. 2008))). and presented under Rule 1006.” Alifax Holding Spa, 404 F. Supp. 3d at 581; cf. Colon-Fontanez v. Municipality of San Juan, 660 F.3d 17, 31 (1st Cir. 2011) (affirming admittance of summary

testimony, in part because the witness’s testimony regarding “her method of preparing and summarizing the exhibits d[id] not an instant expert of her make”); SEC v. Franklin, 265 Fed. Appx. 644, 646 (9th Cir. 2008) (unpublished) (“There was no error in allowing the preparer of the [summary] exhibits to testify because no expert opinions or conclusions were offered.”(citation omitted)). On retrial, this obstacle would prove impassable for Alifax. Any testimony from Bokhart would necessarily be based on his expert knowledge and opinions of the case. Moreover, the materials Bokhart would presumably summarize are not sufficiently voluminous to justify a summary witness, let alone one who has intertwined – and inadmissible – opinions he seeks to share. Therefore, Bokhart

Free access — add to your briefcase to read the full text and ask questions with AI

Alifax Holding Spa v. Alcor Scientific Inc., (D.R.I. 2021).

Alifax Holding Spa v. Alcor Scientific Inc. (Alifax Holding Spa v. Alcor Scientific Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Macaulay v. Anas
321 F.3d 45 (First Circuit, 2003)
United States v. Stierhoff
549 F.3d 19 (First Circuit, 2008)
Esposito v. Home Depot U.S.A., Inc.
590 F.3d 72 (First Circuit, 2009)
Colon-Fontanez v. Municipality of San Juan
660 F.3d 17 (First Circuit, 2011)
Oriental Financial Group, Inc. v. Federal Insurance
483 F. Supp. 2d 161 (D. Puerto Rico, 2007)
Securities & Exchange Commission v. Franklin
265 F. App'x 644 (Ninth Circuit, 2008)